Clinical Trial Update: Pharmacokinetic Study on N-acetylneuraminic Acid [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of N-acetylneuraminic acid conducted by Tohoku University has completed, evaluating pharmacokinetics in the context of Nonaka myop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Inclusion Body Myopathy
• Nonaka Myopathy

Drugs mentioned

• N-acetylneuraminic acid (N-acetylneuraminic acid)

Snippet

Sponsor: Tohoku University | Conditions: Nonaka Myopathy, Hereditary Inclusion Body Myopathy | Phase 1 | Status: COMPLETED